Cumulatively, contemporary guideline-directed medical therapy has reduced mortality in HFrEF by more than 60% over the last 30 years
REF. Heart Failure: A Companion to Braunwald's Heart Disease Fourth Edition
Acute decompensated heart failure(ADHF)에서 VTE 예방을 위한 헤파린
Acute decompensated heart failure(ADHF)에서 이환률과 사망률을 줄이는 증거 기반 약물 투약 시기
Withdrawal of pharmacological treatment for heart failurein patients with recovered dilated cardiomyopathy(TRED-HF): an open-label, pilot, randomised trial
HFrEF 약물 치료의 목적, Goals of pharmacologic therapy of HFrEF